Browsing by Subject "COVID-19-UCH"
Now showing items 1-6 of 6
-
(MDPI, 2022)In December 2019, a case of atypical pneumonia was reported in Wuhan, China. It was named COVID-19 and caused by SARS-CoV-2. In a few months, scientific groups around the world developed vaccines to reduce the disease's ...
-
(Sociedad Chilena Infectología, 2021)El COVID-19 es un problema de salud pública mundial por su carácter epidémico que, a la fecha, carece de tratamiento farmacológico. Sin embargo, ya se cuenta con algunas vacunas autorizadas para uso en emergencia, aunque ...
-
(Elsevier, 2021)SARS-CoV-2 is the third coronavirus emerging in the last two decades producing a disease denominated COVID-19 (infectious disease by coronavirus 2019). It has demostrated to be easily transmisible between humans with a ...
-
(MDPI, 2022)The CoronaVac vaccine is the most used anti-SARS-CoV-2 vaccine worldwide. Previous data indicate that this vaccine produces a lower immune response than RNA vaccines such as BNT162b2. End-stage renal disease (ESRD) patients ...
-
(Medwave Estudios, 2022)Introduction The need for beds and health personnel to treat coronavirus (COVID-19) patients has led to the suspension of many elective surgeries in Chile, including knee arthroplasties. This study aims to determine the ...
-
(Frontiers Media, 2022)Purpose: Endothelial damage and angiogenesis are fundamental elements of neovascularisation and fibrosis observed in patients with coronavirus disease 2019 (COVID-19). Here, we aimed to evaluate whether early endothelial ...